Analysis of clinical outcome risk factors in glioma

[1] Shi, J., Dong, B., Cao, J., Mao, Y., & Wang, S. (2017). Long non-coding rna in glioma: signaling pathways. Oncotarget, 8(16). Search in Google Scholar

[2] Charlton-Perkins, M. A., Sendler, E. D., Buschbeck, E. K., & Cook, T. A. (2017). Multifunctional glial support by semper cells in the drosophila retina. PLoS Genetics, 13(5), e1006782. Search in Google Scholar

[3] Cahill, D. P., & Dunn, G. P. (2023). Considering the extent of resection in diffuse glioma. Neuro-Oncology (12), 12. Search in Google Scholar

[4] Spasic, M., Ninkovic, S., Nedovic, J., Mitrovic, S., & Radovanovic, D. (2019). A borderline phyllodes breast tumor clinicaly presented as giant exulcerated suspicious malignant tumor. The Breast, 44, S125-S126. Search in Google Scholar

[5] Latha, K., Yan, J., Yang, Y., Gressot, L. V., & Rao, G. (2017). Abstract 5606: fibrinogen-like protein 2 drives malignant tumor progression in glioma. Cancer Research, 77(13 Supplement), 5606-5606. Search in Google Scholar

[6] Khain, E., Sander, L. M., & Stein, A. M. (2017). A model for glioma growth. Complexity, 11(2), 53-57. Search in Google Scholar

[7] Johann-Martin Hempel, Sotirios Bisdas, Jens Schittenhelm, Cornelia Brendle, Benjamin Bender, & Henk Wassmann, et al. (2017). In vivo molecular profiling of human glioma using diffusion kurtosis imaging. Journal of Neuro-Oncology. Search in Google Scholar

[8] Hai-Li, Lang, Guo-Wen, Hu, Bo, & Zhang, et al. (2017). Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding rna ccat2. Oncology Reports. Search in Google Scholar

[9] Bingzhou, Cui, Baoshan, Li, Liu, & Youqiang. (2017). Lncrna ccat1 promotes glioma tumorigenesis by sponging mir-181b. Journal of cellular biochemistry. Search in Google Scholar

[10] Gungor, AbuzerDanyeli, Ayca ErsenAkbas, AhmetEksi, Murat SakirGuduk, MustafaOzduman, KorayPamir, M. Necmettin. (2019). Ventricular meningiomas: surgical strategies and a new finding that suggest an origin from the choroid plexus epithelium. World neurosurgery, 129. Search in Google Scholar

[11] A. Basit, K., Huy Q., D., Sricharan, G., Tyler, L., Nisha, G., & Patricia, B., et al. (2023). Clinical outcomes of stereotactic biopsy on children with pontine diffuse midline glioma. Journal of neuro-oncology.(2), 165. Search in Google Scholar

[12] Pacioni, S., D’Alessandris, Quintino Giorgio, Giannetti, S., Morgante, L., Coccè, Valentina, & Bonomi, A., et al. (2017). Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts. Stem Cell Research & Therapy, 8(1), 53. Search in Google Scholar

[13] Thomas, Mathivet, Claire, Bouleti, Matthias, & Van, et al. (2017). Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth. Embo Molecular Medicine. Search in Google Scholar

[14] Jiangfen, Z., Mingyao, L., & Linbo, C. (2021). Radt-16. clinical characteristics and prognosis of adult brain stem glioma: a single-center 10-year retrospective study of 81 patients. Neuro-Oncology (Supplement_6), Supplement_6. Search in Google Scholar

[15] Zhou, Z., Wen, L., Shan, C., Lai, M., & Cai, L. (2020). Tami-31. macrophage m1 invasion predicts poor prognosis of glioma and reveals a strategy for glioblastoma therapy. Neuro-Oncology, 22(Supplement_2), ii219-ii220. Search in Google Scholar

[16] Zhong, ShengFan, YuxiangWu, BoWang, YannanJiang, ShanshanGe, JunliangHua, CongZhao, GangChen, YongXu, Haiyang. (2018). Hdac3 expression correlates with the prognosis and grade of patients with glioma: a diversification analysis based on transcriptome and clinical evidence. World neurosurgery, 119. Search in Google Scholar

[17] Song, L., Zhang, S., Duan, C., Ma, S., Hussain, S., & Wei, L., et al. (2019). Genome‐wide identification of lncrnas as novel prognosis biomarkers of glioma. Journal of Cellular Biochemistry, 120(12). Search in Google Scholar

[18] Zhang, F., Chu, J., & Wang, F. (2017). Expression and clinical significance of cyclooxygenase 2 and survivin in human gliomas. Oncology Letters. Search in Google Scholar

[19] Nazari, P. M. S., Ay, C., Marosi, C., Moik, F., & Berghoff, A. S. (2019). Correlation of systemic and local inflammation with survival prognosis in glioma patients. Journal of Clinical Oncology, 37(15_suppl), 2052-2052. Search in Google Scholar

[20] Kim, D., & Chung, C. K. (2019). The prognosis of diffuse midline glioma h3 k27m mutant. Journal of Clinical Oncology, 37(15_suppl), e13548-e13548. Search in Google Scholar